Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
Abstract
No abstract available for this paper.
Citation impact
536
total citations
- FWCI
- 13.70
- Percentile
- 100%
- References
- 0
Citations per year
Authors
32Topics & keywords
Topics
Keywords
- Immunogenicity
- Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
- Medicine
- Coronavirus disease 2019 (COVID-19)
- 2019-20 coronavirus outbreak
- Virology
- Randomized controlled trial
- Betacoronavirus
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.